Old Information from the Blog Header

This weblog is specially dedicated to my very good friend, Cynthia and her daughter Charmaine, who is my god daughter.

Our feisty princess Charmaine has been diagnosed with neuroblastoma. She is currently in the 4th stage and fighting hard. We are greatly saddened that such a sweet and cheerful little girl has to undergo so much pain and suffering at such a young age.

I'm using this blog as a platform for anyone who wishes to share your stories and experience of having somebody close to you suffering from cancer. Please share your personal experience with neuroblastoma if possible. I would also appreciate if you could leave comments of encouragement for Cynthia and Charmaine. Do sign off with your name or a pseudonym for us to remember you by. =)

To know more about Charmaine and family, please go to http://ourfeistyprincess.com/

In order for us to help Charmaine fight this cancer battle, we require our friends and people who know us to help raise funds for the substantial medical expenses and the expensive treatments.

We would also appreciate if you wish to make alternative contribution arrangements.

If you are keen in donating or helping Cynthia and her family in any way, you may:
- Contact the feisty team at ourfeistyprincess@gmail.com.
- Click here for more information on direct funds donation.

At the very most if you are unable to contribute at this point of time, please take a little time to click on the nuffnang ads above. All proceeds would go into Charmaine's funds.

If you are new to this site, kindly click here to gain a better understanding of the whole situation before proceeding.

Thank you very much.

With warmest regards,
Jolene

Edited to add on 26 June 2009:
Doubling Charmaine's chances of survival

There is an alternative form of treatment for neuroblastoma offered in the US which could double Charmaine's chances of survival. The drug used in the treatment is known as 3F8, which is produced by the white blood cells of mice.

These antibodies are given intravenously to a patient and will circulate in the bloodstream till they attach to a neuroblastoma cell. The patient's own immune system will then attack and kill the neuroblastoma cell.

This treatment has been used in more than 500 patients since 1987.

Source: Memorial Sloan-Kettering Cancer Centre website